Neuron Stem Cells (iNSC) is under clinical development by Allife Medical Science and Technology and currently in Phase II for Ischemic Stroke. According to GlobalData, Phase II drugs for Ischemic Stroke have a 42% phase transition success rate (PTSR) indication benchmark for progressing into Phase III. GlobalData’s report assesses how Neuron Stem Cells (iNSC)’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks. Buy the report here.
Smarter leaders trust GlobalData
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Neuron Stem Cells (iNSC) overview
Stem cell therapy is under development for the treatment of amyotrophic lateral sclerosis (ALS), Parkinson’s disease and ischemic stroke. The therapeutic candidate comprises of human autologous induced pluripotent (iPS) derived neural stem cells (NSC).
For a complete picture of Neuron Stem Cells (iNSC)’s drug-specific PTSR and LoA scores, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s Pharmaceutical Intelligence Center.
